Poor
Poorly Aligned
Patient Risk:
Low
Summary
The response consists primarily of pricing, availability, reimbursement, and distribution claims that are not addressed in the supplied FDA-approved labeling. The formulation claim involving injectable and oral products is also unsupported by the supplied label content. No direct contradictions can be established because no label sections were supplied.
Category Scores
Accurate Statements
Unsupported Statements
The price of pentosan polysulfate sodium varies by strength, pack size, and seller.
Pricing information is not addressed in the supplied FDA-approved labeling.
The price of pentosan polysulfate sodium can differ between branded and generic products.
Brand-versus-generic pricing is not addressed in the supplied FDA-approved labeling.
Pentosan polysulfate sodium is sold in different formulations, including injectable and oral products.
The supplied label sections do not support the existence or approval status of injectable and oral formulations.
The price of pentosan polysulfate sodium typically changes depending on whether it is an injection or an oral product.
Formulation-specific pricing is not addressed in the supplied FDA-approved labeling, and the injectable formulation claim is unsupported.
The price of pentosan polysulfate sodium typically changes with the unit count per pack.
Pack-size pricing is not addressed in the supplied FDA-approved labeling.
The price of pentosan polysulfate sodium typically changes with the size of the intended regimen, such as a monthly supply versus a starter pack.
Regimen-based pricing and starter packs are not addressed in the supplied FDA-approved labeling.
In many markets, generic pentosan polysulfate sodium products are priced lower than branded products.
Market pricing comparisons are not addressed in the supplied FDA-approved labeling.
Availability and reimbursement status can change the effective cost patients pay for pentosan polysulfate sodium.
Availability, reimbursement, and patient out-of-pocket costs are not addressed in the supplied FDA-approved labeling.
Pentosan polysulfate sodium may be available through local retail pharmacies, mail-order pharmacy programs, online pharmacies, or manufacturer or patient-assistance programs.
Distribution channels and assistance programs are not addressed in the supplied FDA-approved labeling.
The total cost of pentosan polysulfate sodium can be affected by insurance coverage and copays.
Insurance coverage and copays are not addressed in the supplied FDA-approved labeling.
The total cost of pentosan polysulfate sodium can be affected by dispensing fees.
Dispensing fees are not addressed in the supplied FDA-approved labeling.
The total cost of pentosan polysulfate sodium can be affected by shipping and cold-chain requirements when applicable to the formulation.
Shipping and cold-chain requirements are not established by the supplied FDA-approved labeling.
The total cost of pentosan polysulfate sodium can be affected by whether the product is in stock or backordered.
Inventory and backorder status are not addressed in the supplied FDA-approved labeling.
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The response does not provide dosing, treatment, or safety instructions. However, the unsupported reference to injectable and oral formulations could create product-identification confusion if interpreted as labeling-based information.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Poorly Aligned
Primary Issue
Nearly all claims concern pricing, reimbursement, distribution, or inventory matters outside the scope of the supplied FDA-approved labeling, and the injectable/oral formulation statement is unsupported.
Suggested Improvement
Clearly identify pricing and access information as outside the FDA label, avoid presenting unsupported formulation claims as label-based facts, and limit a label-alignment response to information contained in the supplied prescribing information.